by Jon Fleetwood, Jon Fleetwood:
All participants had already received prior COVID vaccinations, making it impossible to determine whether observed immunity came from the experimental shot, prior vaccines, or natural infection.
Researchers behind an experimental AI-designed “pan-Sarbecovirus” COVID vaccine recorded 148 separate adverse events among just 39 vaccinated participants during a first-in-human clinical trial published last month in the Journal of Infection.
The vaccine, known as pEVAC-PS, was developed using “Digitally Immune Optimised Synthetic Vaccine” (DIOSynVax) technology and was computationally engineered to target not only SARS-CoV-2, but a broad family of purportedly related bat coronaviruses.
Two NIH researchers are charged with conspiring to smuggle biological materials, including deactivated monkeypox virus samples, into the U.S. from Africa. The researchers work at a Biosafety Level 4 laboratory in Montana. The charges have renewed scrutiny of safety procedures for handling potentially dangerous pathogens.
Secretary of State Marco Rubio tells Senate Foreign Relations Committee.
I asked Claude Opus 4.7 to analyze the data because no public health official wants to know the numbers of COVID vaccine injured. Here are the results of that analysis.
Malaria—primarily spread by mosquitoes—killed at least 597,000 people throughout 83 countries in 2023, according to the CDC.
